USPH(USPH)
USPH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $839M | $896M | $981M |
| Low | $832M | $877M | $966M |
| High | $846M | $912M | $999M |
| EBITDA Avg | $118M | $126M | $138M |
| Low | $117M | $123M | $136M |
| High | $119M | $128M | $141M |
| EBIT Avg | $96M | $102M | $112M |
| Low | $95M | $100M | $110M |
| High | $97M | $104M | $114M |
| Net Income Avg | $42M | $52M | $55M |
| Low | $39M | $48M | $54M |
| High | $45M | $57M | $56M |
| EPS Avg | $2.80 | $3.41 | $3.60 |
| Low | $2.57 | $3.15 | $3.53 |
| High | $2.98 | $3.75 | $3.69 |
| Analysts (Rev / EPS) | 6 / 4 | 6 / 4 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $211M | $212M | $217M | $211M | $224M | $226M | $233M |
| Low | $210M | $210M | $214M | $208M | $221M | $223M | $230M |
| High | $214M | $214M | $221M | $215M | $228M | $230M | $237M |
| EBITDA Avg | $30M | $30M | $31M | $30M | $32M | $32M | $33M |
| Low | $30M | $30M | $30M | $29M | $31M | $31M | $32M |
| High | $30M | $30M | $31M | $30M | $32M | $32M | $33M |
| EBIT Avg | $24M | $24M | $25M | $24M | $26M | $26M | $27M |
| Low | $24M | $24M | $24M | $24M | $25M | $25M | $26M |
| High | $24M | $24M | $25M | $25M | $26M | $26M | $27M |
| Net Income Avg | $12M | $12M | $13M | $8M | $14M | $13M | $15M |
| Low | $11M | $10M | $13M | $8M | $13M | $13M | $15M |
| High | $14M | $13M | $13M | $8M | $14M | $14M | $15M |
| EPS Avg | $0.81 | $0.78 | $0.86 | $0.52 | $0.90 | $0.87 | $1.00 |
| Low | $0.75 | $0.69 | $0.85 | $0.51 | $0.88 | $0.86 | $0.98 |
| High | $0.90 | $0.86 | $0.88 | $0.53 | $0.92 | $0.89 | $1.02 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 4 | 2 / 2 | 2 / 2 | 2 / 1 | 2 / 1 | 2 / 2 |